Systemic Delivery and Biodistribution of Cisplatin in Vivo

Mol Pharm. 2016 Aug 1;13(8):2677-82. doi: 10.1021/acs.molpharmaceut.6b00240. Epub 2016 Jun 24.

Abstract

Cisplatin is widely used to treat a variety of cancers. However, ototoxicity and nephrotoxicity remain serious side effects of cisplatin-based chemotherapy. In order to inform the study of cisplatin's off-target effects, a new drug-fluorophore conjugate was synthesized that exhibited utility as a tracer to determine the cellular uptake and in vivo distribution of cisplatin. This probe will serve as a useful tool to facilitate investigations into the kinetics and biodistribution of cisplatin and its associated side effects in preclinical models after systemic administration.

Keywords: Texas Red; cisplatin; conjugate; ototoxicity; tracer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use*
  • Cisplatin / administration & dosage*
  • Cisplatin / therapeutic use*
  • Dose-Response Relationship, Drug
  • Humans
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Cisplatin